Cancel
Nicholaus Williams
Head of Finance
@
Encoded Therapeutics
About Nicholaus Williams
Nicholaus Williams is the Head of Finance with a strong background in the pharmaceutical and biotechnology sectors, having worked at notable companies such as Dermira, Inc., InterMune, Inc., Onyx Pharmaceuticals, Inc., and Amgen Inc.
Known information
Nicholaus Williams serves as the Head of Finance, bringing a robust educational background with a B.S. in Finance from NC A&T State University and an M.B.A. from Pepperdine University. He began his career as a financial analyst at The Gillette Company, which is now part of Procter & Gamble. Williams has amassed significant experience in the finance sector, particularly within the pharmaceutical and biotechnology industries. He previously held the position of Vice President of Finance at Dermira, Inc., a publicly traded, commercial-stage company. Additionally, he has served in various finance-related roles at InterMune, Inc., Onyx Pharmaceuticals, Inc., and Amgen Inc., further solidifying his expertise and leadership in financial management within these specialized fields.
About Encoded Therapeutics
Encoded Therapeutics focuses on developing precision gene therapies for pediatric central nervous system disorders, with its leading program, ETX101, targeting Dravet syndrome.
Report inaccurate information
